<?xml version="1.0" encoding="UTF-8"?>
<ref id="B53-pathogens-09-00148">
 <label>53.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hurtado</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Acharya</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Lai</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Sun</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Kallolimath</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Steinkellner</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Bai</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>Q.</given-names>
   </name>
  </person-group>
  <article-title>In vitro and in vivo efficacy of anti-chikungunya virus monoclonal antibodies produced in wild-type and glycoengineered 
   <italic>Nicotiana benthamiana</italic> plants
  </article-title>
  <source>Plant Biotechnol. J.</source>
  <year>2020</year>
  <volume>18</volume>
  <fpage>266</fpage>
  <lpage>273</lpage>
  <pub-id pub-id-type="doi">10.1111/pbi.13194</pub-id>
  <pub-id pub-id-type="pmid">31207008</pub-id>
 </element-citation>
</ref>
